Vrije Universiteit Brussel

 

Publications on Stem Cells

Experience with high dose chemotherapy and autologous bone marrow transplantation in testicular cancer
  • Experience with high dose chemotherapy and autologous bone marrow transplantation in testicular cancer.

    Schots R, Storme G.

    J Belge Radiol 76 (2), 98-99 (Review), 1993.

    Abstract:
    Carboplatin based HDCT followed by ABMT produces reasonable response rates (40-60%) and some durable remissions in patients with advanced and cisplatin resistant testicular cancer. Patients eligible for such an approach are those with primary refractory or recurrent disease and low probability for salvage by conventional dose regimens. The use of recombinant human growth factors and peripheral stem cell transplantation will probably reduce the toxicity and mortality of HDCT

 

Back to top

  ©2004-2006 • HEIM • Vrije Universiteit Brussel • Faculteit Geneeskunde & Farmacie • Laarbeeklaan 103 • 1090 Jette • Tel.: (+32)-(0)2-477.44.06 • heim@vub.ac.be